|
Market Closed -
Nasdaq
16:00:00 2026-10-19 EDT
|
5-day change | 1st Jan Change | ||
| 3.820 USD | -0.52% |
|
-17.67% | +90.05% |
| 09-20 | Opus Genetics, Inc.(NasdaqCM:IRD) added to S&P Global BMI Index | CI |
| 09-11 | HEALTH ROUNDS-Experimental eye drops ease night vision problems for drivers | RE |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 319M | - | - | - | ||
| 1,120B | |||||
| 616B | |||||
| 504B | |||||
| 367B | |||||
| 360B |
- Stock Market
- Stocks
- IRD Stock
- Charts Opus Genetics, Inc.
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
